Published in Stroke on February 01, 1988
Mechanisms of second and further strokes. J Neurol Neurosurg Psychiatry (1998) 1.66
Prognostic factors in patients with intracerebral haematoma. J Neurol Neurosurg Psychiatry (1992) 1.38
Long term survival after primary intracerebral haemorrhage: a retrospective population based study. J Neurol Neurosurg Psychiatry (2005) 1.30
Predictors of good outcome in medium to large spontaneous supratentorial intracerebral haemorrhages. J Neurol Neurosurg Psychiatry (2005) 1.21
Primary intracerebral haemorrhage in the Jyväskylä region, central Finland, 1985-89: incidence, case fatality rate, and functional outcome. J Neurol Neurosurg Psychiatry (1992) 1.21
Is hypertension a more frequent risk factor for deep than for lobar supratentorial intracerebral haemorrhage? J Neurol Neurosurg Psychiatry (2006) 1.19
Previous antiplatelet therapy is an independent predictor of 30-day mortality after spontaneous supratentorial intracerebral hemorrhage. J Neurol (2005) 1.17
The risk of recurrent stroke after intracerebral haemorrhage. J Neurol Neurosurg Psychiatry (2007) 0.85
Intracerebral Hemorrhage. Curr Treat Options Neurol (1999) 0.83
Poor outcome in primary intracerebral haemorrhage: results of a matched comparison. Postgrad Med J (2004) 0.83
Spontaneous intracerebral hemorrhage: Clinical and computed tomography findings in predicting in-hospital mortality in Central Africans. J Neurosci Rural Pract (2012) 0.79
Recurrent hypertensive intracerebral haemorrhages: what should we do when a new hemispheric ischaemic event strikes? BMJ Case Rep (2012) 0.75
Relationship between systemic thrombogenic or thrombolytic indices and acute increase of spontaneous intracerebral hemorrhage. J Cerebrovasc Endovasc Neurosurg (2014) 0.75
Functional outcome at 6 months in surgical treatment of spontaneous supratentorial intracerebral haemorrhage. Malays J Med Sci (2008) 0.75
Predictors of 30-day mortality in patients with spontaneous primary intracerebral hemorrhage. Surg Neurol Int (2016) 0.75
Hemorrhagic transformation of ischemic brain tissue: asymptomatic or symptomatic? Stroke (2001) 3.58
Glycine antagonist (gavestinel) in neuroprotection (GAIN International) in patients with acute stroke: a randomised controlled trial. GAIN International Investigators. Lancet (2000) 3.33
Acute stroke: usefulness of early CT findings before thrombolytic therapy. Radiology (1997) 2.77
Cortical motor reorganization in akinetic patients with Parkinson's disease: a functional MRI study. Brain (2000) 2.06
Neurological deterioration in acute ischemic stroke: potential predictors and associated factors in the European cooperative acute stroke study (ECASS) I. Stroke (1999) 1.80
Hemorrhagic transformation of brain infarct: predictability in the first 5 hours from stroke onset and influence on clinical outcome. Neurology (1996) 1.74
Trigeminal neuralgia and pain related to multiple sclerosis. Pain (2009) 1.71
Headache attributed to infection: observations on the IHS classification (ICHD-II). Cephalalgia (2006) 1.69
Morphological and functional characteristics of patent foramen ovale and their embolic implications. Stroke (2000) 1.66
Use of Bacille Calmette-Guèrin (BCG) in multiple sclerosis. Neurology (1999) 1.65
Helicobacter pylori infection and migraine. Cephalalgia (2002) 1.59
Association of hyperdense middle cerebral artery sign with clinical outcome in patients treated with tissue plasminogen activator. Stroke (1999) 1.55
Circulating adhesion molecules and carotid artery structural changes in patients with noninsulin-dependent diabetes mellitus. J Hum Hypertens (2003) 1.51
Early angiographic and CT findings in patients with hemorrhagic infarction in the distribution of the middle cerebral artery. AJNR Am J Neuroradiol (1992) 1.50
Correlation between decreased myocardial glucose phosphorylation and the DNA mutation size in myotonic dystrophy. Circulation (1994) 1.47
A population-based study of the incidence and prognosis of lacunar stroke. Neurology (2006) 1.45
What insights have new imaging techniques given into aggressive forms of MS--different forms of MS or different from MS? Mult Scler (2008) 1.45
Early relapses after the first dose of natalizumab in active multiple sclerosis patients. Mult Scler (2008) 1.44
Evaluation of potential factors affecting the measurement of cerebrovascular reactivity by near-infrared spectroscopy. Clin Sci (Lond) (1998) 1.43
Early prediction of irreversible brain damage after ischemic stroke at CT. Radiology (2001) 1.42
Focal cerebral ischemia in young adults: a collaborative case-control study. The National Research Council Study Group. Neuroepidemiology (1993) 1.40
Hand weakness from a precentral gyrus infarct with intermittent hypotension. Neurology (2001) 1.39
An analysis of which subgroups of multiple myeloma patients, divided according to b(2)-microglobulin and plasma cell labeling index, benefit from high dose vs conventional chemotherapy. Haematologica (1999) 1.39
Computed tomography findings in the first few hours of ischemic stroke: implications for the clinician. J Neurol Sci (2000) 1.38
ICHD-II diagnostic criteria for Tolosa-Hunt syndrome in idiopathic inflammatory syndromes of the orbit and/or the cavernous sinus. Cephalalgia (2008) 1.34
Burden of first-ever ischemic stroke in the oldest old: evidence from a population-based study. Neurology (2004) 1.33
Cardiovascular status of carriers of the apolipoprotein A-I(Milano) mutant: the Limone sul Garda study. Circulation (2001) 1.31
Rifampicin-resistant meningococci causing invasive disease: detection of point mutations in the rpoB gene and molecular characterization of the strains. J Antimicrob Chemother (2001) 1.30
Progressing neurological deficit secondary to acute ischemic stroke. A study on predictability, pathogenesis, and prognosis. Arch Neurol (1995) 1.24
An evaluation of a colour food photography atlas as a tool for quantifying food portion size in epidemiological dietary surveys. Eur J Clin Nutr (2005) 1.24
Association of change in left ventricular mass with prognosis during long-term antihypertensive treatment. J Hypertens (1995) 1.22
Transient embolic occlusion of the middle cerebral and internal carotid arteries in cerebral apoplexy. J Neurol Neurosurg Psychiatry (1969) 1.20
Overweight as an adverse prognostic factor for non-Hodgkin's lymphoma patients receiving high-dose chemotherapy and autograft. Bone Marrow Transplant (2000) 1.19
Serial study of gadolinium-DTPA MRI enhancement in multiple sclerosis. Neurology (1990) 1.17
Neuromyelitis optica spectrum disorders in patients with myasthenia gravis: ten new aquaporin-4 antibody positive cases and a review of the literature. Mult Scler (2011) 1.16
Reversible diffusion MRI abnormalities and transient mutism after liver transplantation. Neurology (2004) 1.16
Phenotypic and cytokine analysis of human peripheral blood gamma delta T cells expressing NK cell receptors. J Immunol (1997) 1.15
Riluzole in cerebellar ataxia: a randomized, double-blind, placebo-controlled pilot trial. Neurology (2010) 1.15
Comparison of cerebral angiography and transcranial Doppler sonography in acute stroke. Stroke (1989) 1.14
Early collateral blood supply and late parenchymal brain damage in patients with middle cerebral artery occlusion. Stroke (1989) 1.14
Prognostic significance of admission levels of troponin I in patients with acute ischaemic stroke. J Neurol Neurosurg Psychiatry (2005) 1.14
Clinical and instrumental evaluation of patients with ischemic stroke within the first six hours. J Neurol Sci (1989) 1.14
Pneumocephalus and tension pneumocephalus after posterior fossa surgery in the sitting position: a prospective study. Acta Neurochir (Wien) (1986) 1.14
Randomized placebo-controlled trial of mitoxantrone in relapsing-remitting multiple sclerosis: 24-month clinical and MRI outcome. J Neurol (1997) 1.12
Various ways of calculating echocardiographic left ventricular mass and their relative prognostic values. J Hypertens (1998) 1.12
Observational case-control study of the prevalence of chronic cerebrospinal venous insufficiency in multiple sclerosis: results from the CoSMo study. Mult Scler (2013) 1.12
Motor recovery after stroke. Morphological and functional brain alterations. Brain (1996) 1.12
Stroke in young adults in the community-based L'Aquila registry: incidence and prognosis. Stroke (2001) 1.10
Embolism to the brain during carotid stenting and surgery. Acta Chir Belg (2007) 1.09
HLA-class I markers and multiple sclerosis susceptibility in the Italian population. Genes Immun (2009) 1.09
Intracranial actinomycosis in juvenile patients. Case report and review of the literature. Childs Nerv Syst (1998) 1.07
Prevalence of dementia in an elderly rural population: effects of age, sex, and education. J Neurol Neurosurg Psychiatry (1996) 1.06
Derangement of regional cerebral blood flow and of its regulatory mechanisms in acute cerebrovascular lesions. Neurology (1968) 1.05
Imaging of leukocytic infiltration in human cerebral infarcts. Stroke (1985) 1.05
A placebo-controlled study of the antidepressant activity of moclobemide, a new MAO-A inhibitor. Pharmacopsychiatry (1984) 1.04
Peripheral white blood cell count in cerebral ischemic infarction. Acta Neurol Scand (1985) 1.01
Migraine and risk of ischaemic heart disease: a systematic review and meta-analysis of observational studies. Eur J Neurol (2015) 1.01
Early spontaneous improvement and deterioration of ischemic stroke patients. A serial study with transcranial Doppler ultrasonography. Stroke (1998) 1.01
Effect of glatiramer acetate on disease reactivation in MS patients discontinuing natalizumab. Eur J Neurol (2012) 1.00
IL-12-mediated NKRP1A up-regulation and consequent enhancement of endothelial transmigration of V delta 2+ TCR gamma delta+ T lymphocytes from healthy donors and multiple sclerosis patients. J Immunol (1999) 1.00
Urinary nitric oxide metabolites and lipid peroxidation by-products in migraine. Cephalalgia (2003) 1.00
Long-term prognosis of cerebral ischemia in young adults. National Research Council Study Group on Stroke in the Young. Stroke (1999) 0.99
Dose-intensive melphalan with stem cell support (MEL100) is superior to standard treatment in elderly myeloma patients. Blood (1999) 0.99
Cerebral atrophy in myotonic dystrophy: a voxel based morphometric study. J Neurol Neurosurg Psychiatry (2004) 0.99
Hyperdense middle cerebral artery CT sign. Comparison with angiography in the acute phase of ischemic supratentorial infarction. Neuroradiology (1991) 0.99
Magnetic resonance imaging changes with recombinant human interferon-beta-1a: a short term study in relapsing-remitting multiple sclerosis. J Neurol Neurosurg Psychiatry (1996) 0.99
Quantitative assessment of blood-brain barrier permeability in multiple sclerosis using 68-Ga-EDTA and positron emission tomography. J Neurol Neurosurg Psychiatry (1988) 0.99
Effects of immunomodulatory treatment with subcutaneous interferon beta-1a on cognitive decline in mildly disabled patients with relapsing-remitting multiple sclerosis. Mult Scler (2009) 0.99
Delayed increase in infarct volume after cerebral ischemia: correlations with thrombolytic treatment and clinical outcome. Stroke (1999) 0.98
Cerebral hemodynamics on MR perfusion images before and after bypass surgery in patients with giant intracranial aneurysms. AJNR Am J Neuroradiol (2001) 0.98
Transcranial Doppler in acute hemispheric brain infarction. Neurology (1991) 0.98
Ergotamine-induced headache can be sustained by sumatriptan daily intake. Cephalalgia (1994) 0.98